Allogeneic Blood Transfusion Does Not Affect Outcome After Curative Resection for Advanced Cholangiocarcinoma

[1]  D. Spahn,et al.  Effects of Allogeneic Red Blood Cell Transfusions on Clinical Outcomes in Patients Undergoing Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis , 2012, Annals of surgery.

[2]  D. Seehofer,et al.  Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma , 2012, Annals of Surgical Oncology.

[3]  R. Grützmann,et al.  Evaluation of the International Study Group of Pancreatic Surgery definition of post-pancreatectomy hemorrhage in a high-volume center. , 2012, Surgery.

[4]  F. Giuliante,et al.  Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. , 2012, Archives of surgery.

[5]  R B D'Agostino,et al.  Frailty models: Applications to biomedical and genetic studies , 2011, Statistics in medicine.

[6]  M. Büchler,et al.  Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome , 2011, Annals of surgery.

[7]  J. Werner,et al.  The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma , 2011, Langenbeck's Archives of Surgery.

[8]  H. Sudhoff,et al.  An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products , 2011, European Archives of Oto-Rhino-Laryngology.

[9]  D. Alvaro,et al.  New insights on cholangiocarcinoma. , 2010, World journal of gastrointestinal oncology.

[10]  D. Gomez,et al.  Surgical technique and systemic inflammation influences long‐term disease‐free survival following hepatic resection for colorectal metastasis , 2008, Journal of surgical oncology.

[11]  M. Büchler,et al.  Liver transection using vascular stapler: a review. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[12]  G. Gores,et al.  Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.

[13]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[14]  Sin-Ho Jung,et al.  A Note on Sample Size Calculation Based on Propensity Analysis in Nonrandomized Trials , 2007, Journal of biopharmaceutical statistics.

[15]  C. Lo,et al.  Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma , 2006, The British journal of surgery.

[16]  B. Hansen,et al.  Optimal Full Matching and Related Designs via Network Flows , 2006 .

[17]  J. Tschmelitsch,et al.  Impact of Blood Transfusions on Recurrence and Survival After Rectal Cancer Surgery , 2006, Diseases of the colon and rectum.

[18]  M. Pescatori,et al.  Perioperative blood transfusions and recurrence of colorectal cancer , 2006 .

[19]  M. Nagino,et al.  One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. , 2005, Surgery.

[20]  S. Fan,et al.  Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary Diseases: Analysis of 1222 Consecutive Patients From a Prospective Database , 2004, Annals of surgery.

[21]  T. Pawlik,et al.  Is Extended Hepatectomy for Hepatobiliary Malignancy Justified? , 2004, Annals of surgery.

[22]  M. Pescatori,et al.  Perioperative blood transfusions for the recurrence of colorectal cancer. , 2004, The Cochrane database of systematic reviews.

[23]  Y. Jan,et al.  Influence of age on surgical treatment of peripheral cholangiocarcinoma. , 2004, American journal of surgery.

[24]  T. Edna,et al.  Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer. , 2003, The European journal of surgery = Acta chirurgica.

[25]  J. Wong,et al.  Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma , 2003, The British journal of surgery.

[26]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[27]  M. Blajchman.  Immunomodulation and Blood Transfusion , 2002, American journal of therapeutics.

[28]  S. Choi,et al.  Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer , 2002, Annals of Surgical Oncology.

[29]  Y. Matsui,et al.  Perioperative blood transfusion in hepatocellular carcinomas , 2001, Cancer.

[30]  P. Rosenbaum,et al.  Invited commentary: propensity scores. , 1999, American journal of epidemiology.

[31]  J. Jeekel,et al.  Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma , 1999 .

[32]  M. Masetti,et al.  Liver resection without blood transfusion , 1995, The British journal of surgery.

[33]  J. Jeekel,et al.  The effect of blood transfusions on survival after surgery for colorectal cancer. , 1995, European journal of cancer.

[34]  M. Blajchman,et al.  Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. , 1995, Hematology/oncology clinics of North America.

[35]  F. Schildberg,et al.  Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[37]  T. Wobbes,et al.  Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer , 1994, The Lancet.

[38]  E. Vamvakas,et al.  Perioperative blood transfusion and colorectal cancer recurrence , 1994, Transfusion.

[39]  M. Makuuchi,et al.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. , 1994, Surgery.

[40]  N. Blumberg,et al.  Blood transfusions and prognosis in colorectal cancer. , 1993, The New England journal of medicine.

[41]  D. Grob,et al.  Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient. , 1988, Archives of internal medicine.

[42]  H. Jaffe,et al.  Transfusion-associated acquired immunodeficiency syndrome in the United States. , 1985, JAMA.

[43]  D. Woodfield,et al.  Relation between cancer of the colon and blood transfusion. , 1985, British medical journal.

[44]  M. Agarwal,et al.  Relation between recurrence of cancer of the colon and blood transfusion. , 1985, British medical journal.

[45]  N. Hyman,et al.  Blood transfusions and survival after lung cancer resection. , 1985, American journal of surgery.

[46]  P. Tartter,et al.  Perioperative blood transfusion has prognostic significance for breast cancer. , 1985, Surgery.

[47]  Xi Chen,et al.  Pathway hunting by random survival forests , 2013, Bioinform..

[48]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[49]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .

[50]  L. Freedman.  Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.